Form 4: Q32 Bio Inc. Executive Jason Campagna Receives and Reprices Stock Options

Q32 Bio Inc.'s Chief Medical Officer, Jason Campagna, received restricted stock units and had existing stock options repriced on February 24, 2025.

Summary

• On February 24, 2025, Jason Campagna, Chief Medical Officer of Q32 Bio Inc., engaged in transactions involving the company's stock.
• Campagna received 37,500 restricted stock units (RSUs) that vest in four equal installments over 36 months from the grant date.
• Existing stock options were repriced by the Issuer's board of directors on the same date.
• The repricing involved multiple tranches of stock options with varying original exercise prices, all adjusted to a new exercise price of $2.54 per share.
• The expiration dates of the options remain unchanged.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine filing related to executive compensation. The repricing could be seen as a positive sign that the company is trying to retain and incentivize its executives, but it could also indicate that the stock price has underperformed.

Positives

• The repricing of stock options could incentivize the executive to improve company performance.
• The vesting schedule of the RSUs aligns the executive's interests with the long-term success of the company.

Risks

• If the executive's employment is terminated for cause or if they resign before the one-year anniversary of the repricing date, the exercise price of the repriced options will revert to the original, higher exercise price.

Industry Context

Stock option repricing is a tool companies use to re-incentivize employees when the stock price has fallen below the option's exercise price. It's common in the biotech industry, where stock prices can be volatile due to the long development timelines and regulatory hurdles.

Comparison to Industry Standards

• Stock option repricing is a relatively common practice, particularly in volatile sectors like biotechnology.
• Many companies, including those in the Russell 2000, have used similar strategies to retain and motivate key employees during periods of stock price decline.
• The vesting schedule of the RSUs is fairly standard, aligning with typical equity compensation plans.

Stakeholder Impact

• The repricing of stock options could be viewed positively by shareholders if it leads to improved company performance.
• The executive is incentivized to increase shareholder value.

Key Dates